Origin Life Sciences, Inc. (OLSI)

Origin Life Sciences will go public soon, but the exact IPO date is still unknown.
IPO Price
Shares Offered
Deal Size
Chart not available yet
Data will show when the stock starts trading.
Market Cap 78.97M
Revenue (ttm) n/a
Net Income (ttm) -8.84M
Shares Out 19.74M
EPS (ttm) -0.45
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Open n/a
Previous Close n/a
Day's Range n/a
52-Week Range n/a
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About OLSI

Origin Life Sciences is a clinical-stage biotechnology company that has been developing a proprietary patented high-energy plasma device that generates nitric oxide (“NO”) in the form of a plasma/NO stream and delivers it to targeted locations of the body. The stream can potentially be used for various therapeutic purposes, including as an anti-infective, anti-inflammatory and tissue-regenerative therapy for chronic wounds and skin and soft tissue infections. The U.S. Food and Drug Administration previously determined that our product will be a... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2010
Employees 7
Ticker Symbol OLSI
Full Company Profile

Financial Performance

Financial Statements


Medical device developer Origin Life Sciences files and sets terms for a $15 million IPO

Origin Life Sciences, which is developing a high-energy plasma medical device for dermal and wound care, filed on Monday with the SEC to raise up to $15 million in an initial public offering.

1 year ago - Renaissance Capital

Origin Life Sciences IPO Registration Document (S-1)

Origin Life Sciences has filed to go public with an IPO on the NYSE American.

1 year ago - SEC